New Year Bumper Sale @ Rs. 1 X
Esgipyrin 50/500 Tablet (10) is a prescription drug, available for use as Tablet. Other than this, Esgipyrin 50/500 Tablet (10) has some other therapeutic uses, which have been discussed ahead.
The right dosage of Esgipyrin 50/500 Tablet (10) depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
The most common side effects of Esgipyrin 50/500 Tablet (10) are Abdominal Pain, Nausea or vomiting, Diarrhoea. Besides the aforementioned side effects, there are other adverse effects of Esgipyrin 50/500 Tablet (10) as well, which are listed below. Usually, these side effects of Esgipyrin 50/500 Tablet (10) go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Esgipyrin 50/500 Tablet (10) has a Mild effect for pregnant women and Mild effect on lactating mothers. In addition, Esgipyrin 50/500 Tablet (10)'s effects on the liver, heart and kidney are discussed below in the Esgipyrin 50/500 Tablet (10) related warnings section.
Esgipyrin 50/500 Tablet (10) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Esgipyrin 50/500 Tablet (10) in conditions like Asthma, Kidney Disease, Heart Attack.
Drug interactions for Esgipyrin 50/500 Tablet (10) have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Esgipyrin 50/500 Tablet (10) is not safe while driving, and is not addiction.
Esgipyrin 50/500 Tablet (10) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Esgipyrin 50/500 Tablet (10) safe for pregnant women?
Esgipyrin has little to no side effects in pregnant women.
Is the use of Esgipyrin 50/500 Tablet (10) safe during breastfeeding?
Breastfeeding women can take Esgipyrin as it bears very minor side effects for them.
What is the effect of Esgipyrin 50/500 Tablet (10) on the Kidneys?
There may be some adverse effects on kidney after taking Esgipyrin. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Esgipyrin 50/500 Tablet (10) on the Liver?
The liver can be affected by Esgipyrin. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Esgipyrin only after medical advice.
What is the effect of Esgipyrin 50/500 Tablet (10) on the Heart?
Esgipyrin may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Esgipyrin 50/500 Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Esgipyrin 50/500 Tablet (10) unless your doctor advises you to do so -
Is this Esgipyrin 50/500 Tablet (10) habit forming or addictive?
Esgipyrin 50/500 Tablet (10) does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Esgipyrin 50/500 Tablet (10) as you may feel sleepy.
Is it safe?
Yes, but consume Esgipyrin 50/500 Tablet (10) only on doctor's advice.
Is it able to treat mental disorders?
No, Esgipyrin 50/500 Tablet (10) cannot treat any kind of mental disorder.
Interaction between Food and Esgipyrin 50/500 Tablet (10)
Taking Esgipyrin 50/500 Tablet (10) with food is safe.
Interaction between Alcohol and Esgipyrin 50/500 Tablet (10)
Information about the interaction of Esgipyrin 50/500 Tablet (10) and alcohol is not currently available because this topic has not been researched yet.
No, Esgipyrin should not be taken in Dengue because it can increase the risk of internal bleeding. Patients should consult a medical professional, take ample rest and drink plenty of fluids. However, paracetamol can be taken to bring down fever and reduce joint aches.
Yes, Esgipyrin can cause stomach upset. It is a common side effect of this drug. Please inform your doctor if you are experiencing stomach upset after taking this medicine.
Esgipyrin is a prescription drug so do not take it without consulting a doctor. It can be harmful for people to take this medicine without a doctor's recommendation.
Yes, Esgipyrin is safe to use, if taken in a prescribed amount for a specified time as advised by the doctor. However, few side effects have been observed such as epigastric pain (stomach pain), nausea, headache, dizziness, rashes, gastric ulceration, and bleeding are less common.
Yes, you can take Esgipyrin for a headache. This drug blocks the pain sensitizing mechanism induced by bradykinin (an inflammatory mediator).
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)